These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 33002119)

  • 1. Latest news on heart failure and atrial fibrillation from the European Society Of Cardiology Congress 2020.
    Savarese G
    Eur Heart J Cardiovasc Pharmacother; 2020 Nov; 6(6):343-344. PubMed ID: 33002119
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anticoagulation Therapy in Atrial Fibrillation and Congestive Heart Failure].
    Tatarsky BA; Kazzenova NV
    Kardiologiia; 2016 Mar; 56(3):54-59. PubMed ID: 28294890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial fibrillation and heart failure: Factors influencing the choice of oral anticoagulant.
    Brown LAE; Boos CJ
    Int J Cardiol; 2017 Jan; 227():863-868. PubMed ID: 28029411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium-Glucose Co-Transporter-2 Inhibitors Decrease the Odds for Atrial Fibrillation in Subjects with Heart Failure.
    Patoulias D; Papadopoulos C; Doumas M
    J Stroke Cerebrovasc Dis; 2022 Mar; 31(3):106257. PubMed ID: 34953683
    [No Abstract]   [Full Text] [Related]  

  • 5. [2016 European Society of Cardiology Guidelines on Atrial Fibrillation: What is new?].
    Özdemir M
    Turk Kardiyol Dern Ars; 2017 Jan; 45(1):1-4. PubMed ID: 28106013
    [No Abstract]   [Full Text] [Related]  

  • 6. Atrial fibrillation and heart failure: update 2015.
    Thihalolipavan S; Morin DP
    Prog Cardiovasc Dis; 2015; 58(2):126-35. PubMed ID: 26192885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral anticoagulants for atrial fibrillation and acute coronary syndrome with or without stenting.
    Muscente F; Tautermann G; De Caterina R
    J Cardiovasc Med (Hagerstown); 2018 Feb; 19 Suppl 1():e40-e45. PubMed ID: 29538143
    [No Abstract]   [Full Text] [Related]  

  • 8. Better clinical outcome with direct oral anticoagulants in hospitalized heart failure patients with atrial fibrillation.
    Yoshihisa A; Sato Y; Sato T; Suzuki S; Oikawa M; Takeishi Y
    BMC Cardiovasc Disord; 2018 Jan; 18(1):11. PubMed ID: 29368593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Causes of Death and Influencing Factors in Patients with Atrial Fibrillation.
    Fauchier L; Villejoubert O; Clementy N; Bernard A; Pierre B; Angoulvant D; Ivanes F; Babuty D; Lip GY
    Am J Med; 2016 Dec; 129(12):1278-1287. PubMed ID: 27476087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catheter ablation of atrial fibrillation and outcomes in heart failure patients: seeking the treasure in the CASTLE.
    Nattel S
    Cardiovasc Res; 2018 Jun; 114(7):e50-e52. PubMed ID: 29800377
    [No Abstract]   [Full Text] [Related]  

  • 11. Heart failure and atrial fibrillation--does practice meet the anticoagulation guidelines?
    Rewiuk K; Wizner B; Fedyk-Łukasik M; Zdrojewski T; Opolski G; Dubiel JS; Gąsowski J; Grodzicki T
    Int J Cardiol; 2012 May; 157(2):274-5. PubMed ID: 22475842
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Lesions.
    Di Biase L
    J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26892528
    [No Abstract]   [Full Text] [Related]  

  • 13. Changes to oral anticoagulant therapy and risk of death over a 3-year follow-up of a contemporary cohort of European patients with atrial fibrillation final report of the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) pilot general registry.
    Boriani G; Proietti M; Laroche C; Diemberger I; Popescu MI; Riahi S; Shantsila A; Dan GA; Tavazzi L; Maggioni AP; Lip GYH;
    Int J Cardiol; 2018 Nov; 271():68-74. PubMed ID: 30001945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is it safe to stop oral anticoagulation after catheter ablation for atrial fibrillation?
    Romero J; Avendano R; Diaz JC; Taveras J; Lupercio F; Di Biase L
    Expert Rev Cardiovasc Ther; 2019 Jan; 17(1):31-41. PubMed ID: 30460874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rhythm control in atrial fibrillation.
    Piccini JP; Fauchier L
    Lancet; 2016 Aug; 388(10046):829-40. PubMed ID: 27560278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uninterrupted administration of edoxaban vs vitamin K antagonists in patients undergoing atrial fibrillation catheter ablation: Rationale and design of the ELIMINATE-AF study.
    Hohnloser SH; Camm J; Cappato R; Diener HC; Heidbuchel H; Lanz HJ; Mont L; Morillo CA; Smolnik R; Yin OQP; Kautzner J
    Clin Cardiol; 2018 Apr; 41(4):440-449. PubMed ID: 29663464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reasons for and consequences of oral anticoagulant underuse in atrial fibrillation with heart failure.
    Savarese G; Sartipy U; Friberg L; Dahlström U; Lund LH
    Heart; 2018 Jul; 104(13):1093-1100. PubMed ID: 29371374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heart Failure and Mortality in Patients With Nonvalvular Atrial Fibrillation Started on Novel Oral Anticoagulant Therapy: A Single-Center Experience.
    Sunbul M; Oguz M; Dogan Z; Atas H; Bozbay M; Cincin A; Agirbasli M
    Clin Appl Thromb Hemost; 2017 Jul; 23(5):454-459. PubMed ID: 26566667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Ethics of Conducting Clinical Trials With Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure: Is Placebo Assignment Justified in Patients With Comorbid Diabetes Mellitus and Heart Failure?
    Butler J; Anker SD
    Circulation; 2017 Oct; 136(16):1459-1461. PubMed ID: 29038205
    [No Abstract]   [Full Text] [Related]  

  • 20. Ablation for persistent atrial fibrillation in patients with heart failure: is it underutilized?
    Pappone C; Santinelli V
    J Cardiovasc Med (Hagerstown); 2018 Feb; 19 Suppl 1():e99-e102. PubMed ID: 29538154
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.